Coumarin-3-carboxylic acid derivatives as potentiators and inhibitors of recombinant and native N-methyl-d-aspartate receptors

Neurochemistry International

Volumn 61, Issue 4, 2012, Pages 593-600

  Irvine, Mark W ^a   Costa, Blaise M ^b   Volianskis, Arturas ^a   Fang, Guangyu ^a   Ceolin, Laura ^a   Collingridge, Graham L ^a   Monaghan, Daniel T ^b   Jane, David E ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Allosteric modulator; Antagonist; Glutamate; Hippocampus; NMDA receptors; Oocyte

Indexed keywords

6 (2 CARBOXYETHEN 1 YL)COUMARIN 3 CARBOXYLIC ACID; 6 BROMO 4 METHYLCOUMARIN 3 CARBOXYLIC ACID; 6 BROMOCOUMARIN 3 CARBOXYLIC ACID; 6,8 DIIODOCOUMARIN 3 CARBXYLIC ACID; BENZO[5,6]COUMARIN 3 CARBOXYLIC ACID; COUMARIN 3 CARBOXYLIC ACID DERIVATIVE; COUMARIN DERIVATIVE; ETHYL 6 (2 ETHOXYCARBONYLETHEN 1 YL)COUMARIN 3 CARBOXYLATE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; UBP 608; UBP 656; UBP 658; UBP 659; UBP 714; UNCLASSIFIED DRUG;

ARTICLE; DEPRESSION; EPILEPSY; FEMALE; HIPPOCAMPAL CA1 REGION; NEUROPATHIC PAIN; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

ANIMALS; COUMARINS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE; RECOMBINANT PROTEINS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 84865766723     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2011.12.020     Document Type: Article

References (38)

1. B. Aebischer, P. Frey, H.P. Haerter, P.L. Herrling, W.A. Mueller, H.J. Olverman, and J.C. Watkins Synthesis and NMDA antagonist properties of the enantiomers of 4-(3-phosphonopropyl)piperazine-2-carboxylic acid (CPP) and of the unsaturated analogue (E)-4-(3-phosphonoprop-2-enyl)piperazine-2-carboxylic acid (CPP-ene) Helvetica Chimica Acta 72 1989 1043 1051
2. A.C. Arai, and M. Kessler Pharmacology of ampakine modulators: from AMPA receptors to synapses and behavior Curr. Drug Targets 8 2007 583 602
3. Y.P. Auberson, H. Allgeier, S. Bischoff, K. Lingenhoehl, R. Moretti, and M. Schmutz 5-Phosphonomethylquinoxalinediones as competitive NMDA receptor antagonists with a preference for the human 1A/2A, rather than 1A/2B receptor composition Bioorg. Med. Chem. Lett. 12 2002 1099 1102
4. T.E. Bartlett, N.J. Bannister, V.J. Collett, S.L. Dargan, P.V. Massey, Z.A. Bortolotto, S.M. Fitzjohn, Z.I. Bashir, G.L. Collingridge, and D. Lodge Differential roles of NR2A and NR2B-containing NMDA receptors in LTP and LTD in the CA1 region of two-week old rat hippocampus Neuropharmacology 52 2007 60 70
5. E. Bettini, A. Sava, C. Griffante, C. Carignani, A. Buson, and A.M. Capelli Identification and characterisation of novel NMDA receptor antagonists selective for NR2A- over NR2B-containing receptors J. Pharmacol. Exp. Ther. 335 2010 636 644
6. T.V.P. Bliss, and G.L. Collingridge A synaptic model of memory - long-term potentiation in the hippocampus Nature 361 1993 31 39
7. L. Bonsignore, F. Cottiglia, S.M. Lavagna, G. Loy, and D. Secci Synthesis of coumarin-3-O-acylisoureas by different carbodiimides Heterocycles 50 1999 469 478
8. A.L. Buller, H.C. Larson, B.E. Schneider, J.A. Beaton, R.A. Morrisett, and D.T. Monaghan The molecular basis of NMDA receptor subtypes: native receptor diversity is predicted by subunit composition J. Neurosci. 14 1994 5471 5484
9. J.P. Conn, A. Christopoulos, and C.W. Lindsley Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders Nat. Rev. Drug Discov. 8 2009 41 54
10. B.M. Costa, B. Feng, T.S. Tsintsadze, R.M. Morley, M.W. Irvine, V. Tsintsadze, N.A. Lozovaya, D.E. Jane, and D.T. Monaghan N-methyl-d-aspartate (NMDA) receptor NR2 subunit selectivity of a series of novel piperazine-2,3-dicarboxylate derivatives: preferential blockade of extrasynaptic NMDA receptors in the rat hippocampal CA3-CA1 synapse J. Pharmacol. Exp. Ther. 331 2009 618 626
11. B.M. Costa, M.W. Irvine, G. Fang, R.J. Eaves, M.B. Mayo-Martin, D.A. Skifter, D.E. Jane, and D.T. Monaghan A novel family of negative and positive allosteric modulators of NMDA receptors J. Pharmacol. Exp. Ther. 335 2010 614 621
12. R.H. Evans, A.A. Francis, A.W. Jones, D.A.S. Smith, and J.C. Watkins The effects of a series of ω-phosphonic α-carboxylic amino acids on electrically evoked and amino acid induced responses in isolated spinal cord preparations Br. J. Pharmacol. 75 1982 65 75
13. B. Feng, R.M. Morley, D.E. Jane, and D.T. Monaghan The effect of competitive antagonist chain length on NMDA receptor subunit selectivity Neuropharmacology 48 2005 354 359
14. B. Feng, H.W. Tse, D.A. Skifter, R. Morley, D.E. Jane, and D.T. Monaghan Structure-activity analysis of a novel NR2C/NR2D-preferring NMDA receptor antagonist: 1-(phenanthrene-2-carbonyl) piperazine-2,3-dicarboxylic acid Br. J. Pharmacol. 141 2004 508 516
15. Hrabetova, S.; Serrano, P.; Blace, N.; Tse, H-W.; Jane, D.E.; Monaghan, D.T.; Sacktor, T.C.; 2000. Distinct N-methyl-d-aspartate receptor subpopulations contribute to LTP and LTD induction. J. Neurosci. 20, RC81.
16. Jane, D.E.; Tse, H.W.; Skifter, D.A.; Christie, J.M.; Monaghan, D.T.; 2000. Glutamate receptor ion channels: Activators and inhibitors. In: Endo, M.; Kurachi.; Y.; Mishina, M. (Eds.), Handbook of Experimental Pharmacology: Pharmacology of Ionic Channel Function: Activators and Inhibitors. Springer, Berlin, pp. 415-478.
17. L.V. Kalia, S.K. Kalia, and M.W. Salter NMDA receptors in clinical neurology: excitatory times ahead Lancet Neurol. 7 2008 742 755
18. H. Khosravani, Y. Zhang, S. Tsutsui, S. Hameed, C. Altier, and J. Hamid Prion protein attenuates excitotoxicity by inhibiting NMDA receptors J. Gen. Physiol. 131 2008 i5
19. P.D. Leeson, and L.L. Iversen The glycine site on the NMDA receptor: structure-activity relationships and therapeutic potential J. Med. Chem. 37 1994 4053 4067
20. C.W. Lindsley, W.D. Shipe, S.E. Wolkenberg, C.R. Theberge, D.L. Williams Jr.; and C. Sur Progress towards validating the NMDA receptor hypofunction hypothesis of schizophrenia Curr. Top. Med. Chem. 6 2006 771 785
21. D. Lodge, and K.M. Johnson Noncompetitive excitatory amino acid receptor antagonists Trends Pharmacol. Sci. 11 1990 81 86
22. D.R. Lynch, J.J. Lawrence, S. Lenz, N.J. Anegawa, M. Dichter, and D.B. Pritchett Pharmacological characterization of heterodimeric NMDA receptors composed of NR1a and 2B subunits: differences with receptors formed from NR1a and 2A J. Neurochem. 64 1995 1462 1468
23. H. Monyer, R. Sprengel, R. Schoepfer, A. Herb, M. Higuchi, and H. Lomeli Heteromeric NMDA receptors: molecular and functional distinction of subtypes Science 256 1992 1217 1221
24. K. Moriyoshi, M. Masu, T. Ishii, R. Shigemoto, N. Mizuno, and S. Nakanishi Molecular cloning and characterization of the rat NMDA receptor Nature 354 1991 31 37
25. 1-substituted piperazine-2,3- dicarboxylic acid derivatives acting as NMDA receptor antagonists J. Med. Chem. 48 2005 2627 2637
26. C.A. Mosley, T.M. Acker, K.B. Hansen, P. Mullasseril, K.T. Andersen, and P. Le Quinazolin-4-one derivatives: a novel class of noncompetitive NR2C/D subunit-selective N-methyl-d-aspartate receptor antagonists J. Med. Chem. 53 2010 5476 5490
27. P. Mullasseril, K.B. Hansen, K.M. Vance, K.K. Ogden, H. Yuan, and N.L. Kurtkaya A subunit-selective potentiator of NR2C- and NR2D-containing NMDA receptors Nat. Commun. 1 2010 1 8
28. R.A. Murphy, H.F. Kung, M.P. Kung, and J. Billings Synthesis and characterization of iodobenzamide analogues: potential D-2 dopamine receptor imaging agents J. Med. Chem. 33 1990 171 178
29. G. Sanacora, C.A. Zarate, J.H. Krystal, and H.K. Manji Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders Nature Rev. Drug. Discov. 7 2008 426 437
30. A.I. Sobolevsky, M.P. Rosconi, and E. Gouaux X-ray structure, symmetry and mechanism of an AMPA-subtype glutamate receptor Nature 462 2009 745 758
31. A. Song, X. Wang, and K.S. Lam A convenient synthesis of coumarin-3-carboxylic acids via Knoevenagel condensation of Meldrum's acid with ortho-hydroxyaryl aldehydes or ketones Tet. Lett. 44 2003 1755 1758
32. Y. Sun, R. Olson, M. Horning, N. Armstrong, M. Mayer, and E. Gouaux Mechanism of glutamate receptor desensitization Nature 417 2002 245 253
33. S.F. Traynelis, L.P. Wollmuth, C.J. McBain, F.S. Menniti, K.M. Vance, and K.K. Ogden Glutamate receptor ion channels: structure, regulation, and function Pharmacol. Rev. 62 2010 405 496
34. C. Villmann, and C.M. Becker On the hypes and falls in neuroprotection: targeting the NMDA receptor Neuroscientist 13 2007 594 615
35. A. Volianskis, and M.S. Jensen Transient and sustained types of long-term potentiation in the CA1 area of the rat hippocampus J. Physiol. 550 2003 459 492
36. C.G. Wasterlain, and J.W. Chen Mechanistic and pharmacologic aspects of status epilepticus and its treatment with new antiepileptic drugs Epilepsia 49 2008 63 73
37. J.C. Watkins, and D.E. Jane The glutamate story Br. J. Pharmacol. 147 2006 S100 S108
38. K. Williams Ifenprodil discriminates subtypes of the N-methyl-d-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors Mol. Pharmacol. 44 1993 851 859